COVID-19大流行对欧洲风湿与骨骼肌肉疾病患者影响的评估:REUMAVID研究(第一阶段)结果
REUMAVID是一项横断面在线调查研究,覆盖欧洲七国未选择的风湿与骨骼肌肉疾病(RMD)患者,评估COVID-19大流行对医疗可及性、日常活动、疾病活动度与功能、幸福感、健康状况、焦虑抑郁及信息获取的影响。第一阶段(2020年4-7月)纳入1800例15种RMD患者,发现风湿科预约取消、信息获取不足、不良生活习惯增加,自报疾病活动度高、疼痛普遍,近半数幸福感差,焦虑抑郁风险高。结论认为第一波疫情期间RMD患者医疗中断、生活方式不佳且身心健康受损,COVID-19信息未适当传达给患者。
要点
- 58.4%患者风湿科预约被取消,45.6%未收到SARS-CoV-2感染对RMD影响的相关信息。
- 45.6%无法继续锻炼,24.6%吸烟增加,18.2%饮酒增加。
- 自报疾病活动度高(5.3±2.7),75.6%报告疼痛升高,49.0%幸福感差,57.3%有焦虑风险,45.9%有抑郁风险。
核心结论
- 第一波COVID-19疫情期间,RMD患者经历医疗服务可及性中断、不良生活习惯及整体健康、幸福感和心理健康的负面影响。
- COVID-19相关信息未适当传达给RMD患者。
研究设计与样本
- REUMAVID为横断面研究,采用由国际多学科患者主导合作开发的在线调查,覆盖欧洲七国未选择的RMD患者。
- 第一阶段数据收集于2020年4月至7月,纳入1800例15种不同RMD患者。
主要发现
- 患者中37.2%为中轴型脊柱关节炎,29.2%为类风湿关节炎,17.2%为骨关节炎及其他;平均年龄53岁,80%为女性,49%有大学学历。
- 58.4%患者风湿科预约被取消,45.6%未收到SARS-CoV-2感染对RMD可能影响的信息,主要信息来源为患者组织(27.6%)。
- 24.6%吸烟增加,18.2%饮酒增加,45.6%无法继续锻炼。
- 自报疾病活动度高(5.3±2.7),75.6%报告疼痛升高;49.0%报告幸福感差(WHO-5),46.6%报告封锁期间健康状况变差。
- 根据HADS,57.3%有焦虑风险,45.9%有抑郁风险。
临床怎么用
- 风湿免疫科医生在公共卫生危机期间应主动保障RMD患者的风湿科随访可及性,减少预约取消带来的疾病管理中断。
- 应通过患者组织等渠道向RMD患者主动提供COVID-19相关影响信息,并关注其生活方式、疼痛、幸福感和焦虑抑郁风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM: To assess the impact of the COVID-19 pandemic on patients with rheumatic and musculoskeletal diseases (RMDs). METHODS: REUMAVID is a cross-sectional study using an online survey developed by an international multidisciplinary patient-led collaboration across seven European countries targeting unselected patients with RMDs. Healthcare access, daily activities, disease activity and function, well-being (WHO Five Well-Being Index (WHO-5)), health status, anxiety/depression (Hospital Anxiety and Depression Scale (HADS)) and access to information were evaluated. Data were collected in April-July 2020 (first phase). RESULTS: Data from the first phase included 1800 patients with 15 different RMDs (37.2% axial spondyloarthritis, 29.2% rheumatoid arthritis, 17.2% osteoarthritis and others). Mean age was 53, 80% female and 49% had undertaken university studies. During the beginning of the pandemic, 58.4% had their rheumatology appointment cancelled and 45.6% reported not having received any information relating to the possible impact of SARS-CoV-2 infection in their RMDs, with the main source being patient organisations (27.6%).Regarding habits, 24.6% increased smoking, 18.2% raised their alcohol consumption, and 45.6% were unable to continue exercising. Self-reported disease activity was high (5.3±2.7) and 75.6% reported elevated pain. Half the patients (49.0%) reported poor well-being (WHO-5) and 46.6% that their health had changed for the worse during lockdown. According to HADS, 57.3% were at risk of anxiety and 45.9% of depression. CONCLUSION: Throughout the first wave of the COVID-19 pandemic, patients with RMDs have experienced disruption in access to healthcare services, poor lifestyle habits and negative effects on their overall health, well-being and mental health. Furthermore, information on COVID-19 has not reached patients appropriately.
引用
- Garrido-Cumbrera M, Marzo-Ortega H, Christen L, et al. Assessment of impact of the COVID-19 pandemic from the perspective of patients with rheumatic and musculoskeletal diseases in Europe: results from the REUMAVID study (phase 1). RMD Open. 2021. PMID: 33827969. doi:10.1136/rmdopen-2020-001546
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。